Providing analysts with a standardised approach to data entry, analysis and reporting of the APSD of drug output from metered dose inhalers (MDIs), dry powder inhalers (DPIs) and nebulisers in accordance with European and US Pharmacopoeial specifications, Inhalytix® requires minimal installation, is easy to set-up and needs no specialist IT knowledge to use.
Fully validated, the software will accept data from standard and customised versions of a wide range of impactor and impinger types, including the Next Generation Impactor (NGI), Andersen Cascade Impactor (ACI), Fast Screening Impactor (FSI), Fast Screen Andersen (FSA), Glass Twin Impinger (GTI) and Multi-Stage Liquid Impinger (MSLI).
Compliant with 21 CFR Part 11, ISO and GxP standards, Inhalytix® outputs APSD data that meets both Ph. Eur and USP submission requirements.
Find key information including the latest tests prepared and executed, as well as a summary of test, equipment and report configurations on the Inhalytix® dashboard upon login.
Choose either a “Summary” or “Detailed” report and select which metrics are to be reported
Keep track of the equipment inventory with ease, using the Inhalytix® asset library and ensure full traceability by assigning specific equipment with specific test methods.
Easy as a click of a button, Inhalytix® auto validation could not be easier.
Assign the appropriate level of access to users dependent on their role.
